Vitamin D and Fertility: Why Your Level Matters

You are pre-trying or in early cycles, you live somewhere with long winters, you wear sunscreen, you work indoors, or you have darker skin, and you have read that vitamin D matters for fertility. You are wondering whether to take 4,000 international units (IU) because more must be better, or whether you should actually test first. The honest answer on vitamin D fertility: deficiency is common, easy to fix, and plausibly linked to fertility outcomes. That is reason enough to test and repair before trying. It is not reason to take mega-doses if your level is already adequate.

I want to write this post with two things visible at the same time: deficiency is real, common, and worth correcting, and mega-dosing is not a fertility intervention. Both are true, and the supplement marketing has confused them.

Why vitamin D fertility is a real list item

Vitamin D receptors are expressed in the ovaries, the endometrium (uterine lining), the placenta, and the testes. That alone is not proof of a clinical role, but it is consistent with vitamin D having functions beyond bone health. Animal data and human observational studies link adequate vitamin D status to ovulation, implantation, pregnancy maintenance, and a lower rate of pregnancy complications including gestational diabetes and pre-eclampsia.

Deficiency is genuinely common. National diet and nutrition surveys in the UK suggest that roughly one in six adults has a 25-hydroxyvitamin D (25(OH)D) level below 25 nanomoles per litre in winter.⁴ Rates are higher in South Asian, Middle Eastern, and Black populations regardless of latitude. In the United States, similar disparities exist along skin pigmentation and sun exposure lines.

This is one of the few fertility supplements where the indication overlaps with a separate medically important deficiency state. You are not taking vitamin D primarily to "boost fertility"; you are correcting a likely deficiency that has consequences for fertility, for pregnancy, and for general health. It sits alongside folate and iodine as a genuine preconception supplement, rather than in the marketing pile.

What the evidence says, and where it stops

The evidence base sits in a particular shape that is worth understanding clearly.

• Observational data: consistently link low 25(OH)D to lower in vitro fertilisation (IVF) live-birth rates, longer time-to-pregnancy, and a higher rate of miscarriage. The Aghajafari meta-analysis in BMJ in 2013 pooled observational studies and found low maternal 25(OH)D associated with gestational diabetes, pre-eclampsia, and small-for-gestational-age babies.³
• Randomised trials: trials of vitamin D supplementation in IVF have shown inconsistent effects on clinical pregnancy and live birth. Doses, baseline status, and outcome definitions have varied widely across studies, which makes pooling difficult.
• Meta-analysis of supplementation: Chu and colleagues in Human Reproduction in 2018 found that women with sufficient 25(OH)D had higher rates of clinical pregnancy and live birth in assisted reproductive technology (ART) compared with women who were deficient or insufficient, but supplementation evidence was lower quality.¹
• Pregnancy outcomes: vitamin D deficiency has a stronger association with adverse pregnancy outcomes (gestational diabetes, pre-eclampsia, preterm birth) than with conception itself. Some of the strongest reasons to fix vitamin D are about the pregnancy that follows, not about the conception.

The honest line, the one I use in clinic: replete if low; do not pretend mega-dosing fertilises eggs. Vitamin D is necessary for many things. It is rarely the binding constraint that decides whether or not you conceive in a given cycle.

The numbers that actually matter

This is the part where unit confusion most often trips people up.

Units

• Most UK and European laboratories report 25(OH)D in nanomoles per litre (nmol/L).
• Most US laboratories report in nanograms per millilitre (ng/mL).
• Conversion: ng/mL multiplied by 2.5 equals nmol/L. So 30 ng/mL is 75 nmol/L. So 20 ng/mL is 50 nmol/L.

Confirm which units your laboratory is using before interpreting any number on a report. The same patient with a "30" in the UK is far worse off than the same patient with a "30" in the US.

Reference cut-offs

The most widely used cut-offs:

• Deficient: less than 25 nmol/L (less than 10 ng/mL).
• Insufficient: 25 to 50 nmol/L (10 to 20 ng/mL).
• Adequate: 50 to 125 nmol/L (20 to 50 ng/mL).
• High but not toxic: 125 to 250 nmol/L (50 to 100 ng/mL). Toxicity is rare and usually requires sustained supraphysiological dosing over months.

The preconception target

Most reproductive medicine reviews suggest aiming above 75 nmol/L (30 ng/mL) preconception. This is higher than the National Health Service (NHS) "adequate" threshold of 50 nmol/L, and it is supported by reproductive outcome data that show a step-up in benefit when 25(OH)D crosses into that higher range. The Endocrine Society clinical practice guideline takes a similar view for groups at higher risk of deficiency.⁵

For most people, the practical target is "above 75 nmol/L, ideally between 75 and 125." That is the range I aim for in patients preparing for assisted conception or recurrent loss workup.

Who to test

I do not recommend universal preconception vitamin D testing for every reader. The cohorts where I do recommend testing if it is accessible:

• Anyone preparing for IVF or being worked up for recurrent loss.
• Anyone living at a higher latitude through autumn and winter (most of the UK, northern Europe, the northern US, Canada).
• Anyone with darker skin tones, which reduces cutaneous vitamin D synthesis.
• Anyone with limited sun exposure (indoor work, full-coverage clothing, consistent sunscreen use).
• Anyone with malabsorption (inflammatory bowel disease, celiac disease, post-bariatric surgery, or chronic pancreatic disease).
• Anyone with a body mass index (BMI) over 30. Vitamin D is fat-soluble and sequesters in adipose tissue, which blunts the dose-response to supplementation.
• Anyone on certain medications: long-term glucocorticoids, certain antiepileptics, some antiretrovirals.
• Anyone with a personal or family history of osteomalacia or unexplained bone pain.

I test 25(OH)D in every patient preparing for assisted conception, and at least once preconception for anyone with risk factors for deficiency. If your GP cannot arrange it on the NHS, a private finger-prick test is available for around twenty to thirty pounds and provides the same number.

Dose, form, and timing

If you cannot test in time

The NHS recommendation of 400 IU (10 micrograms) of vitamin D daily through autumn and winter is the safety net.⁴ For preconception, a reasonable baseline is 1,000 IU (25 micrograms) daily, taken with a fat-containing meal. This is unlikely to push anyone into toxic range and is enough to nudge most adults towards adequate.

If you test and you are insufficient (25 to 50 nmol/L)

1,000 to 2,000 IU daily for eight to twelve weeks, then retest. Many people maintain adequacy on 1,000 to 2,000 IU as a long-term dose, particularly through winter months.

If you test and you are deficient (less than 25 nmol/L)

4,000 IU daily for eight to twelve weeks, then retest. Once you cross into adequate range, drop to a maintenance dose of 1,000 to 2,000 IU.

Some clinicians prefer a loading approach: 50,000 IU once weekly for six weeks, or 20,000 IU twice weekly for six weeks. Both are acceptable. The total dose ends up similar to a daily 4,000 IU course. I usually pick the regimen the patient is most likely to adhere to.

Form

Vitamin D3 (cholecalciferol) is preferred over vitamin D2 (ergocalciferol). D3 is better at raising 25(OH)D and is the form supported by most modern dosing guidelines.

Tablet, capsule, and oral spray are all fine. Take with a meal that contains some fat, because vitamin D is fat-soluble. Absorption from an oral spray is comparable to capsules in most studies.

Timing

25(OH)D has a half-life of two to three weeks, which means daily dosing is not strictly necessary. Weekly equivalent dosing works in adherence settings where daily is unrealistic. The bigger variable is consistency over time rather than perfection on any given day.

What vitamin D does NOT replace

I want to be explicit about a few things vitamin D is sometimes incorrectly assumed to do.

Vitamin D does not replace a prenatal multivitamin. Most prenatals contain some vitamin D, often 400 to 1,000 IU. If you are using a prenatal and adding separate vitamin D, check the total daily dose so you do not under-dose or over-dose.

Vitamin D does not replace calcium and weight-bearing exercise for bone health. It is one input. The skeletal system needs the other inputs too.

Vitamin D does not treat an underlying malabsorption. If you have undiagnosed celiac disease, IBD, or a similar condition, your 25(OH)D will not stay corrected even with adequate supplementation. The next step is the underlying diagnosis, not a bigger dose.

Vitamin D does not fix your thyroid-stimulating hormone (TSH) if that is also off. Preconception, both deserve checking; they are independent issues with independent corrections.

What to do this week

A practical sequence:

1. Ask your GP whether 25(OH)D can be added to your next blood panel if you are pre-conception and have any of the risk factors above. In the UK, it is often available on the NHS for a clinical indication. Otherwise a private finger-prick test is twenty to thirty pounds.
2. If you cannot test in time, start vitamin D3 1,000 IU daily with a meal that contains some fat (breakfast with eggs, lunch with avocado, dinner with olive oil). Reassess once a number is available.
3. Anchor the dose to a habit you already have: brushing teeth, coffee, the morning prenatal.
4. Do not stack a 4,000 IU separate tablet on top of a prenatal already containing 1,000 IU "just in case." Add the dose to what you already have, do not duplicate it.

When to involve your clinician

Some scenarios warrant more than a standard supplementation approach.

• Documented deficiency that has not responded to eight to twelve weeks of supplementation: suspect malabsorption or non-adherence. Underlying workup is the next step.
• Persistent fatigue, bone pain, or muscle weakness alongside low 25(OH)D: worth a fuller workup for osteomalacia and parathyroid function.
• Pre-existing hyperparathyroidism, sarcoidosis, or granulomatous disease: these conditions alter vitamin D handling, and dosing should be supervised.
• Concurrent thiazide diuretics, digoxin, or high-dose calcium supplements: higher vitamin D doses interact with these and need careful monitoring.
• Pregnancy: once you have a positive test, continue vitamin D as part of your prenatal plan. Most national guidelines recommend ongoing supplementation through pregnancy and breastfeeding.

A note on cost honesty

A year's supply of vitamin D3 at 1,000 to 2,000 IU daily costs under fifteen pounds at any pharmacy or supermarket. There is no premium "fertility vitamin D" worth buying. The molecule is the molecule.

If you can afford to test once preconception, do that. It costs less than a single month of a premium prenatal and gives you a number to base the dose on, which is more useful than guessing. That is the realistic vitamin D fertility answer: test, replete, then forget about it.

What's next

• For the full female preconception stack including folate, choline, and iodine: read the preconception supplement stack.
• For prenatal multivitamin choice and what to look for on the label: read prenatal vitamins: when to start and which to pick.
• If you have PCOS: read myo-inositol and D-chiro inositol for PCOS fertility.
• If you are 35 or older or have low ovarian reserve: read CoQ10 for egg quality.
• For the broader preconception window: see the section hub for preparing your body.

Sources

1. Chu J, Gallos I, Tobias A, Tan B, Eapen A, Coomarasamy A. Vitamin D and assisted reproductive treatment outcome: a systematic review and meta-analysis. Hum Reprod 2018;33(1):65-80. Link
2. Pilz S, Zittermann A, Obeid R, et al. The role of vitamin D in fertility and during pregnancy and lactation: a review of clinical data. Int J Environ Res Public Health 2018;15(10):2241. Link
3. Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi DM. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ 2013;346:f1169. Link
4. Scientific Advisory Committee on Nutrition. Vitamin D and Health. London: SACN; 2016. Link
5. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96(7):1911-1930. Link
6. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84(1):18-28. Link
7. NHS. Vitamin D: Vitamins and minerals. Link